Barbara Klencke, Director at TScan Therapeutics, Inc. (TCRX), bought 10,000 shares at $5.53 ($56K) on 2024-08-26, disclosed to the SEC on 2024-08-27.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.69 | 5,000 | $28K | 50.7% |
| 2 | $5.53 | 5,000 | $28K | 49.3% |
| Total | $5.61 avg | 10,000 | $56K | 100% |
| Filing → |
| SRRA | BUY | 2020-08-18 | $113K | — | Filing → |
| SRRA | BUY | 2019-08-26 | $101K | — | Filing → |